Bacitracin Zinc: adverse event reports in all combinations
Active ingredient, alone and in combinations
Brand names with this ingredient: Vetropolycin, Bac-Neo-Poly, Mycitracin, Cortisporin Veterinary, Neosporin, Deccox and Albac, and 12 more.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.
From December 2011 to March 2026, FDA received 81 adverse event reports that name a drug with bacitracin zinc, alone or in a combination. One set of active ingredients with bacitracin zinc has a drug page.
Of the 81 reports, 67 (82.7%) are about dogs. 11 reports are about cats (13.6%). In January to March 2026, FDA received 2 reports that name bacitracin zinc, alone or in a combination. The signs that appear in the largest number of the 81 reports are "Corneal ulcer", "Ocular discharge" and "Vomiting". A report is not proof that a drug caused a sign.
Fewer than 20 reports named this ingredient in the 12 months before June 2026, so this page gives no change. Reports about dogs are 82.7% of the reports that name this ingredient, and 72.6% of all reports.
Search engines list an ingredient page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.
Reports in the latest closed quarter
| Species | Jan to Mar 2026 | Oct to Dec 2025 | Jan to Mar 2025 |
|---|---|---|---|
| All species | 2 | 2 | 1 |
| Dog | 2 | 2 | 1 |
| Cat | 0 | 0 | 0 |
| Horse | 0 | 0 | 0 |
| Other or not given | 0 | 0 | 0 |
January to March 2026 is the latest closed quarter in the data.
Drug pages with bacitracin zinc
A report names a drug by its set of active ingredients. Each set with bacitracin zinc that has a drug page is in the table, in order of name. The table has one set.
| Active ingredients | Reports, all years | Reports, latest 12 months |
|---|---|---|
| Bacitracin Zinc | 49 | 5 |
A report can name more than one set, so the counts of the sets can add to more than the count of the page.
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 81 reports that list the sign. One report can list more than one sign and more than one drug.
The sign that is in the largest number of the reports comes first.
- Corneal ulcer19.8%16 reports
- Ocular discharge17.3%14 reports
- Vomiting17.3%14 reports
- Diarrhoea[diarrhea]16%13 reports
- Other abnormal test result NOS[abnormal laboratory result, type not specified]16%13 reports
- Keratoconjunctivitis sicca14.8%12 reports
- Schirmer tear test14.8%12 reports
- Lethargy[unusually tired or inactive]13.6%11 reports
- Blepharospasm11.1%9 reports
- Corneal disorder NOS[NOS: not otherwise specified]9.9%8 reports
- Dry nose8.6%7 reports
- Lack of efficacy - NOS[the product did not have the expected effect]8.6%7 reports
- Nasal discharge8.6%7 reports
- Nystagmus[rapid involuntary eye movement]8.6%7 reports
Show the next 16 signs
- Squinting8.6%7 reports
- Decreased appetite7.4%6 reports
- Emesis[vomiting]7.4%6 reports
- Ataxia[unsteady, uncoordinated movement]6.2%5 reports
- Behavioural disorder NOS[behaviour change, type not specified]6.2%5 reports
- Erythema (for urticaria see Immune SOC)6.2%5 reports
- Eye pain6.2%5 reports
- Head tilt - ear disorder6.2%5 reports
- Skin lesion NOS[NOS: not otherwise specified]6.2%5 reports
- Weight loss6.2%5 reports
- Conjunctivitis4.9%4 reports
- Corneal oedema4.9%4 reports
- Cough4.9%4 reports
- Ear infection NOS[NOS: not otherwise specified]4.9%4 reports
- Eye redness4.9%4 reports
Reports by species
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 2 | 0 | 0 | 0 | 2 |
| 2025 | 9 | 0 | 0 | 0 | 9 |
| 2024 | 3 | 1 | 0 | 0 | 4 |
| 2023 | 3 | 1 | 0 | 0 | 4 |
| 2022 | 3 | 2 | 0 | 0 | 5 |
| 2021 | 8 | 1 | 0 | 3 | 12 |
| 2020 | 9 | 1 | 0 | 0 | 10 |
| 2019 | 1 | 2 | 0 | 0 | 3 |
| 2018 | 4 | 0 | 0 | 0 | 4 |
| 2017 | 5 | 0 | 0 | 0 | 5 |
| 2016 | 8 | 2 | 0 | 0 | 10 |
| 2015 | 4 | 0 | 0 | 0 | 4 |
| 2014 | 3 | 0 | 0 | 0 | 3 |
| 2013 | 1 | 1 | 0 | 0 | 2 |
| 2012 | 3 | 0 | 0 | 0 | 3 |
| 2011 | 1 | 0 | 0 | 0 | 1 |
2026 has the reports that FDA received through Mar 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal22.2%18
- Recovered with Sequela[recovered, with a lasting effect]1.2%1
- Ongoing22.2%18
- Died2.5%2
- Euthanized1.2%1
- Outcome Unknown46.9%38
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 81 reports that name bacitracin zinc.
Kind of report
- Safety issue74.1%60
- Lack of expected effectiveness7.4%6
- Both safety and lack of expected effectiveness12.3%10
- Manufacturing or product defect6.2%5
- Other0%0
Age of the animal
- Under 1 year13.6%11
- 1 to 3 years21%17
- 4 to 7 years25.9%21
- 8 to 11 years21%17
- 12 years and over12.3%10
- Age not given6.2%5
Each share of kind and age is of the 81 reports that name bacitracin zinc.
Approved animal drugs with this active ingredient (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Vetropolycin
- Bac-Neo-Poly
- Mycitracin
- Cortisporin Veterinary
- Neosporin
- Deccox and Albac
- Baciferm
- Coban plus Baciferm
- Robenz
- Albac
- Amprol Hi-E
- CobanTM and Albac
The Green Book has 6 more brand names with this active ingredient. Brand names A to Z
What the Green Book records give
- Applications with an approval in force
- 30
- Approved species
- Chickens, Cats, Dogs, Turkeys, Quail, Pheasants, Swine, Cattle
- Dose forms
- Medicated Feed, Type A medicated articles to be used in the manufacture of Type C medicated feeds, Ointment, Liquid (Solution), Type A Medicated Article
- Routes
- Oral, Ophthalmic
- Sale
- OTC (over the counter), RX (prescription)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Deccox and Albac | Bacitracin Zinc, Decoquinate | Phibro Animal Health Corp. | Chickens | NADA 045-348 |
| Baciferm - 10; Baciferm - 25; Baciferm - 40; Baciferm - 50 | Bacitracin Zinc | Zoetis Inc. | Cattle, Swine, Chickens, Turkeys | NADA 046-920 |
| Coban plus Baciferm | Bacitracin Zinc, Monensin | Elanco US Inc. | Chickens | NADA 047-933 |
| Coyden 25 with Bacitracin Zinc | Bacitracin Zinc, Clopidol | Huvepharma EOOD | Chickens | NADA 049-934 |
| Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment; Vetropolycin HC Ophthalmic Ointment | Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, Polymyxin B Sulfate | Dechra Veterinary Products LLC | Dogs, Cats | NADA 065-015 |
| Bac-Neo-Poly Ophthalmic Ointment; Vetropolycin Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Dechra Veterinary Products LLC | Dogs, Cats | NADA 065-016 |
| Mycitracin Sterile Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Zoetis Inc. | Dogs, Cats | NADA 065-114 |
| Baciferm Soluble 50 | Bacitracin Zinc | Zoetis Inc. | Chickens | NADA 065-313 |
| Cortisporin Veterinary Ophthalmic Ointment | Bacitracin Zinc, Hydrocortisone, Neomycin Sulfate, Polymyxin B Sulfate | Intervet, Inc. | Dogs, Cats | NADA 065-476 |
| Neosporin Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Intervet, Inc. | Dogs, Cats | NADA 065-485 |
| Robenz and Baciferm | Bacitracin Zinc, Robenidine Hydrochloride | Phibro Animal Health Corp. | Chickens | NADA 096-933 |
| Albac 50 Type A Medicated Article | Bacitracin Zinc | Zoetis Inc. | Swine, Chickens, Turkeys | NADA 098-452 |
| Amprol Hi-E and Baciferm | Amprolium, Bacitracin Zinc, Ethopabate | Phibro Animal Health Corp. | Chickens | NADA 114-794 |
| CobanTM and Albac | Bacitracin Zinc, Monensin | Phibro Animal Health Corp. | Chickens | NADA 134-830 |
| Bio-Cox and Baciferm | Bacitracin Zinc, Salinomycin Sodium | Phibro Animal Health Corp. | Chickens | NADA 139-235 |
| Monteban and Albac; Monteban and Baciferm | Bacitracin Zinc, Narasin | Phibro Animal Health Corp. | Chickens | NADA 140-865 |
| Avatec / Baciferm | Bacitracin Zinc, Lasalocid | Phibro Animal Health Corp. | Chickens | NADA 141-083 |
| Avatec / Baciferm | Bacitracin Zinc, Lasalocid | Phibro Animal Health Corp. | Turkeys | NADA 141-109 |
| Nicarb / Baciferm | Bacitracin Zinc, Nicarbazin | Phibro Animal Health Corp. | Chickens | NADA 141-146 |
| Avatec and Albac | Bacitracin Zinc, Lasalocid | Phibro Animal Health Corp. | Turkeys | NADA 141-181 |
| Baciferm / Sacox | Bacitracin Zinc, Salinomycin Sodium | Huvepharma EOOD | Chickens | ANADA 200-089 |
| Albac / Bio-Cox | Bacitracin Zinc, Salinomycin Sodium | Phibro Animal Health Corp. | Chickens | ANADA 200-204 |
| Amprol Hi-E and Albac | Amprolium, Bacitracin Zinc, Ethopabate | Phibro Animal Health Corp. | Chickens | ANADA 200-205 |
| Sacox and Albac | Bacitracin Zinc, Salinomycin Sodium | Phibro Animal Health Corp. | Chickens | ANADA 200-210 |
| Robenz and Albac | Bacitracin Zinc, Robenidine Hydrochloride | Phibro Animal Health Corp. | Chickens | ANADA 200-212 |
| Deccox and Albac | Bacitracin Zinc, Decoquinate | Phibro Animal Health Corp. | Chickens | ANADA 200-213 |
| Coyden and Albac | Bacitracin Zinc, Clopidol | Phibro Animal Health Corp. | Chickens | ANADA 200-218 |
| Albac 50 Type A Medicated Article | Bacitracin Zinc | Zoetis Inc. | Cattle, Swine, Chickens, Turkeys | ANADA 200-223 |
| Nicarb and Albac | Bacitracin Zinc, Nicarbazin | Phibro Animal Health Corp. | Chickens | ANADA 200-478 |
| Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Domes Pharma S.A. | Dogs, Cats | ANADA 200-553 |
| Bonaid-Zinc Bacitracinapproval withdrawn | Bacitracin Zinc, Buquinolate | Proctor & Gamble Pharmaceuticals, Inc. | Not in the list of major species | NADA 035-314 |
| Bonaid & Zinc Bacitracin & Penicillinapproval withdrawn | Bacitracin Zinc, Buquinolate, Penicillin G Procaine | Proctor & Gamble Pharmaceuticals, Inc. | Not in the list of major species | NADA 035-315 |
| Broiler Finisher Premix; Broiler Starter Premixapproval withdrawn | Bacitracin Zinc, Roxarsone, Zoalene | Roche Vitamins, Inc. | Not in the list of major species | NADA 040-395 |
| Coyden 25 with Roxarsone and Bacitracin Zincapproval withdrawn | Bacitracin Zinc, Clopidol, Roxarsone | Huvepharma EOOD | Chickens | NADA 044-016 |
| 3-Nitro / Deccox / Albacapproval withdrawn | Bacitracin Zinc, Decoquinate, Roxarsone | Zoetis Inc. | Chickens | NADA 091-326 |
| Rainbow Broiler Base Concentrateapproval withdrawn | Amprolium, Bacitracin Zinc, Ethopabate | Stockton Hay & Grain Co. | Chickens | NADA 091-646 |
| Amprol HI-E / Baciferm / 3-Nitroapproval withdrawn | Amprolium, Bacitracin Zinc, Ethopabate, Roxarsone | Zoetis Inc. | Chickens | NADA 105-758 |
| 3-Nitro-10 / Baciferm / Coban Premixapproval withdrawn | Bacitracin Zinc, Monensin, Roxarsone | Zoetis Inc. | Chickens | NADA 123-154 |
| 3-Nitro / Avatec / Bacifermapproval withdrawn | Bacitracin Zinc, Lasalocid, Roxarsone | Zoetis Inc. | Chickens | NADA 126-052 |
| Anchor Zinc Bacitracinapproval withdrawn | Bacitracin Zinc | Pennfield Oil Co. | Chickens | NADA 128-550 |
| Baciferm / Carb-O-Sepapproval withdrawn | Bacitracin Zinc, Carbarsone | Zoetis Inc. | Turkeys | NADA 136-484 |
| 3-Nitro / Albac / Bio-Coxapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Zoetis Inc. | Chickens | NADA 137-536 |
| 3-Nitro / Albac / Cobanapproval withdrawn | Bacitracin Zinc, Monensin, Roxarsone | Zoetis Inc. | Chickens | NADA 138-703 |
| 3-Nitro / Bio-Cox / Bacifermapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Zoetis Inc. | Chickens | NADA 139-190 |
| Albac and Histostatapproval withdrawn | Bacitracin Zinc, Nitarsone | Zoetis Inc. | Turkeys | NADA 141-132 |
| 3-Nitro / Albac / Sacoxapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Huvepharma EOOD | Chickens | ANADA 200-086 |
| 3-Nitro / Baciferm / Sacoxapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Huvepharma EOOD | Chickens | ANADA 200-143 |
| Albac / Carb-O-Sepapproval withdrawn | Bacitracin Zinc, Carbarsone | Zoetis Inc. | Turkeys | ANADA 200-203 |
| 3-Nitro / Albac / Deccoxapproval withdrawn | Bacitracin Zinc, Decoquinate, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-206 |
| 3-Nitro / Albac / Coyden 25approval withdrawn | Bacitracin Zinc, Clopidol, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-207 |
| Avatec / 3-Nitro / Albacapproval withdrawn | Bacitracin Zinc, Lasalocid, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-208 |
| 3-Nitro / Albac / Sacoxapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Zoetis Inc. | Chickens | ANADA 200-209 |
| 3-Nitro / Albac / Cobanapproval withdrawn | Bacitracin Zinc, Monensin, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-211 |
| 3-Nitro / Albac / Amprol Hi-Eapproval withdrawn | Amprolium, Bacitracin Zinc, Ethopabate, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-214 |
| 3-Nitro / Albac / Bio-Coxapproval withdrawn | Bacitracin Zinc, Roxarsone, Salinomycin Sodium | Zoetis Inc. | Chickens | ANADA 200-215 |
| 3-Nitro / Albac / Amprol Hi-Eapproval withdrawn | Amprolium, Bacitracin Zinc, Ethopabate, Roxarsone | Zoetis Inc. | Chickens | ANADA 200-217 |
FDA pages for this ingredient
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 065-015The FDA record of the application for Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment, Vetropolycin HC Ophthalmic Ointment.
- Green Book record of NADA 065-016The FDA record of the application for Bac-Neo-Poly Ophthalmic Ointment, Vetropolycin Ophthalmic Ointment.
- Green Book record of NADA 065-114The FDA record of the application for Mycitracin Sterile Ophthalmic Ointment.
- Green Book record of NADA 065-476The FDA record of the application for Cortisporin Veterinary Ophthalmic Ointment.
- Green Book record of NADA 065-485The FDA record of the application for Neosporin Ophthalmic Ointment.
- Green Book record of ANADA 200-553The FDA record of the application for Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Bacitracin Zinc, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/bacitracin-zinc/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.
- Do the reports show that the ingredient caused the signs?
No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 7 reports in the 12 months to June 2026. It received 8 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 81 reports received from December 2011 to March 2026, 74.1% are about a safety issue only. 19.8% are about a lack of expected effectiveness, alone or with a safety issue. 6.2% are about a defect of the product or its package.